Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/39359

Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry


no-thumbnailVer/Abrir:

 Mortality reduction in older COVID‑19‑patients.pdf



1,59 MB
Adobe PDF
Compartir:

Este recurso está restringido

Título :
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Autor :
Casas Rojo, José Manuel  
Antón-Santos, Juan-Miguel
Millán-Núñez-Cortés, Jesús
Gómez Huelgas, Ricardo  
Ramos Rincón, José Manuel  
Rubio-Rivas, Manuel  
Corrales-González, Miguel Ángel
Fernández-Madera-Martínez, María Rosa
Beato-Pérez, José Luis
Arnalich-Fernández, Francisco
gallego lezaun, cristina  
Pérez Martínez, Pablo
Molinos Castro, Sonia  
Tung Chen, Yale  
Madrazo, Mauel
Editor :
Nature
Departamento:
Departamentos de la UMH::Medicina Clínica
Fecha de publicación:
2023-10
URI :
https://hdl.handle.net/11000/39359
Resumen :
In 2020, the COVID-19 pandemic followed a two-wave pattern in most countries. Hospital admission for COVID-19 in one wave or another could have affected mortality, especially among the older persons. The objective of this study was to evaluate whether the admission of older patients during the different waves, before SARS-CoV-2 vaccination was available, was associated with a different mortality. We compared the mortality rates of patients hospitalized during 2020 before (first wave) and after (second wave) July 7, 2020, included in the SEMI-COVID-19 Registry, a large, multicenter, retrospective cohort of patients admitted to 126 Spanish hospitals for COVID-19. A multivariate logistic regression analysis was performed to control for changes in either the patient or disease profile. As of December 26, 2022, 22,494 patients had been included (17,784 from the first wave and 4710 from the second one). Overall mortality was 20.4% in the first wave and 17.2% in the second wave (risk difference (RD) - 3.2%; 95% confidence interval (95% CI) - 4.4 to - 2.0). Only patients aged 70 and older (10,973 patients: 8571 in the first wave and 2386 in the second wave) had a significant reduction in mortality (RD - 7.6%; 95% CI - 9.7 to - 5.5) (unadjusted relative risk reduction: 21.6%). After adjusting for age, comorbidities, variables related to the severity of the disease, and treatment received, admission during the second wave remained a protective factor. In Spain, patients aged 70 years and older admitted during the second wave of the COVID-19 pandemic had a significantly lower risk of mortality, except in severely dependent persons in need of corticosteroid treatment. This effect is independent of patient characteristics, disease severity, or treatment received. This suggests a protective effect of a better standard of care, greater clinical expertise, or a lesser degree of healthcare system overload.
Palabras clave/Materias:
COVID-19
SARS-CoV-2 vaccination
Tipo de documento :
info:eu-repo/semantics/article
Derechos de acceso:
info:eu-repo/semantics/restrictedAccess
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
DOI :
10.1038/s41598-023-42735-5
Publicado en:
Sci Rep . 2023 Oct 18;13(1):17731
Aparece en las colecciones:
Artículos Medicina Clínica



Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.